Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Ecopipam Hydrochloride
DRUG
2 trials
Sponsors
Emalex Biosciences Inc.
Conditions
QT/QTc
Tourette Disorder
Phase 1
Thorough QT/QTc Study to Evaluate the Effects of Ecopipam (EBS-101) on Cardiac Repolarization
Completed
NCT05841160
Emalex Biosciences Inc.
QT/QTc
Start: 2023-03-15
End: 2023-05-12
Updated: 2023-06-09
Phase 3
Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults
Completed
NCT05615220
Emalex Biosciences Inc.
Tourette Disorder
Start: 2023-01-31
End: 2025-02-04
Updated: 2026-06-12
Related Papers
Efficacy and Safety of Ecopipam for Tourette Syndrome: A Phase 3 Randomized Clinical Trial.
2026-05-26